slides · global inventory
Problem Agitate Solution Problem Identify Pain
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,748
Current window 2,971-3,000
Pages 125
Rows per page 30
Beat
2,971-3,000 of 3,748
07
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide uses a comparison frame to contrast small molecule data availability with biologic data scarcity.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
03
Uses a rhetorical question to frame the company's value proposition as a paradigm shift.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Uses a process diagram to illustrate the iterative, inefficient nature of traditional drug discovery.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The chart is a scatter plot showing maintenance remission rates vs. dosing frequency, positioning current therapies in a cluster and the company's target in a superior quadrant.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The chart uses a visual metaphor of an arrow pointing from current standard of care (SOC) to a higher efficacy/convenience target.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
15
The slide uses a visual comparison to illustrate two distinct evasion strategies: starving killer T-cells and recruiting protective T-reg cells.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
16
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
17
The slide uses a split-screen layout to compare channel volume trends against regional HD adoption metrics.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
18
The slide contrasts a stacked area chart showing the growth of HD/UHD channels against a table detailing channel capacity per 36 Mhz transponder.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
19
The chart highlights the growth gap in fiber penetration across different European markets.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
20
The slide uses two bar charts to compare 2020 and 2030e market sizes for the total market and the NGSO segment specifically.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
Exscientia | Investor Presentation Deck | 69 slidesExscientia | Investor Presentation Deck | 69 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a chevron-style separator to imply causality between the two lists.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
06
The slide uses a strategic framework to group markets into 'Consolidate/Invest' vs 'Optimise/Maintain' categories, mapping them to financial performance metrics.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
06
Uses a value-chain style diagram to show the complexity of the current manual process.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
07
The slide uses a map-based hub-and-spoke visual to connect specific industry pain points to the global supply chain.Freightos | Investor Presentation Deck | 33 slides · Freightos
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
Genius Group | Investor Presentation Deck | 29 slidesGenius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Problem (Identify pain)1 hit
04
Hipgnosis Songs Fund | Results Presentation Deck | 22 slidesHipgnosis Songs Fund | Results Presentation Deck | 22 slides · Hipgnosis Songs Fund
Activist deck Investor relations Beat · Problem (Identify pain)1 hit
03
The slide uses a circular central graphic to anchor the list of pain points.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a wave-like visual to represent market segments and their associated financial opportunities.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
Uses a visual icon array to represent the '1 in 4' statistic.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a numbered list format to categorize the problem into four distinct areas: clinical outcomes, cost/length of stay, reimbursement losses, and readmission penalties.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit
07
Includes medical citations for each claim.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit
08
Includes medical citations at the bottom.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Problem1 hit